ARCHIVES

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

Mytomycin C, RT Improve Head & Neck Results, Sartorelli Reports; Other AACR, ASCO Lectures

June 5, 1987

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation

November 13, 1992

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007